Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 297

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study

Open access
Bauer, Jason W., Petri, Michelle, Batliwalla, Franak M., Koeuth, Thearith, Wilson, Joseph, Slattery, Catherine, Panoskaltsis‐Mortari, Angela, Gregersen, Peter K., Behrens, Timothy W., Baechler, Emily C.·2009·Arthritis & Rheumatism

Abstract

Objective: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares of disease activity and irreversible damage to multiple organ systems. An earlier study showed that SLE patients carrying an interferon (IFN) gene expression signature in blood have elevated serum levels of IFN‐regulated chemokines. These chemokines were associated with more‐severe and active disease and showed promise as SLE disease activity biomarkers. This study was designed to validate IFN‐regulated chemokines as biomarkers of SLE disease activity in 267 SLE patients followed up longitudinally. Methods: To validate the potential utility of serum chemokine levels as biomarkers of disease activity, we measured serum levels of CXCL10 (IFNγ‐inducible 10‐kd protein), CCL2 (monocyte chemotactic protein 1), and CCL19 (macrophage inflammatory protein 3β) in an independent cohort of 267 SLE patients followed up longitudinally over 1 year (1,166 total clinic visits). Results: Serum chemokine levels correlated with lupus activity at the current visit ( P = 2 × 10 −10 ), rising at the time of SLE flare ( P = 2 × 10 −3 ) and decreasing as disease remitted ( P = 1 × 10 −3 ); they also performed better than the currently available laboratory tests. Chemokine levels measured at a single baseline visit in patients with a Systemic Lupus Erythematosus Disease Activity Index of ≤4 were predictive of lupus flare over the ensuing year ( P = 1 × 10 −4 ). Conclusion: Monitoring serum chemokine levels in SLE may improve the assessment of current disease activity, the prediction of future disease flares, and the overall clinical decision‐making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.24803

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 297

Metadata

Authors
Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2009-09-29
Volume
60
Issue
10
Pages
3098-3107
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2127198764
Cited by
297
References
30
FWCI
15.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. https://app.cochat.ai/papers/10.1002/art.24803
The paper
Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C. (2009). Interferon‐regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis & Rheumatism. https://doi.org/10.1002/art.24803

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.